Clinical Trial Update: Efficacy and Safety Study of Velaglucerase Alfa in Children and Adolescents With Type 3 Gaucher Disease [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial updates the efficacy and safety of velaglucerase alfa in children and adolescents with Type 3 Gaucher disease, completed with results posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gaucher Disease Type 3

Drugs mentioned

• Velaglucerase alfa (velaglucerase alfa)

Snippet

Sponsor: Shire | Conditions: Gaucher Disease, Type 3 | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2015-10-30